Christopher R. LoPalo
Christopher R. LoPalo is an experienced litigator who manages the firm’s Pharmaceutical and World Trade Center Departments. His practice primarily focuses on the litigation of complex mass tort litigations involving products liability, personal injury, medical malpractice, wrongful death, environmental, negligence and class actions all over the country. Mr. LoPalo has been an integral player in successfully recovering hundreds of millions of dollars on behalf of the firm’s clients since joining the firm.
Mr. LoPalo’s clients typically include individuals throughout the country who were seriously injured by large corporations or municipalities such as Wyeth, Pfizer, Glaxosmithkline, Bayer, Johnson & Johnson, Janssen, Hoffmann-LaRoche, Merck, Eli Lilly, Organon, Takeda, Bristol-Myers Squibb, Boehringer Ingelheim and the City of New York.
- Bar Admissions
- New York
- United States District, Southern District of New York
- United States District, Eastern District of New York
- Hofstra University School of Law, J.D.
- State University of New York at Oswego, B.A.
- Awards and Honors
- Lawyers of Distinction, 2018
- New York Metro Super Lawyers, 2012-2018
- New York Super Lawyers, Metro Rising Stars, 2012
- Speaking Engagements
- Representative Cases and Settlements of Note
In re: World Trade Center Disaster Site Litigation, 21 MC 100 (AKH) and 21 MC 102 (AKH), United States District Court, Southern District of New York. Mr. LoPalo played an integral role in the historic settlement of more than ten thousand workers’ claims against the City of New York, its contractors and other defendants in the mass tort litigation where first responders, construction workers and laborers became ill as a result of toxic exposures suffered during the debris removal and clean up operations at the World Trade Center and related sites following the September 11, 2001 attacks. Additionally, Mr. LoPalo resolved hundreds of claims involving workers who cleaned-up the buildings surrounding the World Trade Center Site.
In re: NuvaRing ® Litigation: Mr. LoPalo’s clients participated in the $100 Million NuvaRing Resolution Program for compensation for blood clotting injuries caused by a birth control device.
In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation: Mr. LoPalo’s clients participated in the $650 Million Pradaxa Master Settlement Program for compensation for their bleeding injuries caused by blood thinners.
In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation: Mr. LoPalo’s clients obtained millions of dollars for blood clotting injuries caused by birth control pills.
In re: Trasylol Products Liabilty Litigation: Mr. LoPalo’s clients obtained millions of dollars a result of being administered the defective drug Trasylol during heart surgery.
In re: Diet Drug (Phentermine, fenfluramine, dexfenfluramine) Products Liability Litigation: Mr. LoPalo’s clients obtained close to a billion dollars as a result of heart injuries from defective diet medications.
- Other Experience
- Napoli Bern Ripka Shkolnik LLP